LLY Eli Lilly and Co
- 820.340
- +5.280+0.65%
- 823.500
- +3.160+0.39%
Eli Lilly and Co News
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Hedley Mary Lynne
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 8-K: Voting Results of Annual Shareholders' Meeting
Eli Lilly and Co | SD: Specialized disclosure report
Eli Lilly and Co | 10-Q: Quarterly report
Eli Lilly and Co | 8-K: Eli Lilly and Co Reports First-Quarter 2024 Financial Results
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H
Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director LUCIANO JUAN R
Analysis
Price Target
No Data
